Google
AllNewsImagesShopping Maps Videos Books
Search tools
Archives
  • Recent
  • Past hour
  • Past 24 hours
  • Past week
  • Past month
  • Past year
  • Archives
Sorted by relevance
Clear

The Sinovac-CoronaVac COVID-19 vaccine: What you need to know

World Health Organization (WHO)
How efficacious is the vaccine? A large phase 3 trial in Brazil showed that two doses, administered at an interval of 14 days, had an efficacy...
31 months ago

How the Sinovac Vaccine Works (Published 2022)

The New York Times
Once vaccinated with CoronaVac, the immune system can respond to an infection of live coronaviruses. B cells produce antibodies that stick to the invaders.
48 months ago

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

The New England Journal of Medicine
Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine...
42 months ago

Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patients

Nature
We show a reduction in immunity 6-months of Sinovac-CoronaVac 2nd dose, particularly in males and those under immunosuppressives therapies, without a...
27 months ago

Sinovac (CoronaVac) COVID-19 vaccine: Safety and side effects

MedicalNewsToday
According to the data, the most common side effect reported within 28 days of the second dose was injection-site pain (13–21%, depending on the dosing schedule)...
43 months ago

Covid: What do we know about China's coronavirus vaccines?

BBC
China appears to have made huge strides, with vaccines from two front-runners - Sinovac and Sinopharm - already making their way abroad.
48 months ago

WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations

World Health Organization (WHO)
WHO today validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries, funders, procuring agencies and communities...
43 months ago

These countries used Chinese vaccines and still have Covid-19 cases

CNN
Questions over the efficacy of China's Sinopharm and Sinovac vaccines now jeopardize that soft-power win for Beijing.
42 months ago

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

The Lancet
With the unprecedented morbidity and mortality associated with the COVID-19 pandemic, a vaccine against COVID-19 is urgently needed.
50 months ago

Malaysia approves Sinovac's COVID-19 vaccine for ages 12 to 17

Reuters
Malaysia has given conditional approval for a COVID-19 vaccine made by China's Sinovac to be used on young people aged between 12 and 17,...
39 months ago